Baker Bros. Advisors LP Ionis Pharmaceuticals Inc Transaction History
Baker Bros. Advisors LP
- $8.39 Billion
- Q1 2025
A detailed history of Baker Bros. Advisors LP transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Baker Bros. Advisors LP holds 357,915 shares of IONS stock, worth $12.6 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
357,915
Previous 357,915
-0.0%
Holding current value
$12.6 Million
Previous $12.5 Million
13.7%
% of portfolio
0.13%
Previous 0.14%
Shares
2 transactions
Others Institutions Holding IONS
# of Institutions
401Shares Held
146MCall Options Held
916KPut Options Held
552K-
Vanguard Group Inc Valley Forge, PA16.4MShares$577 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$570 Million0.32% of portfolio
-
Capital World Investors Los Angeles, CA12.4MShares$436 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$364 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.42MShares$297 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...